Pharmaceutical preparation for treating nadh-caused diseases
作者： Johannes Huber
DOI:
关键词:
摘要: The invention relates to a pharmaceutical preparation containing, independently of each other, - 1 mg 10 g, preferably 1000 mg, more 500 in particular 50 300 epigallocatechin gallate (EGCG), 100 20 80 nicotinamide ribose (NR), and/or 0.05 0.1 5 0.5 3 tryptophan.
lens.org 参考文章(15)
Pete Maletto, Daniel Maiullo, Composition for treatment of obesity or generally aiding weight loss in pill, powder or liquid form, by appetite reduction and metabolism increase, comprising: L- phenylalanine, caffeine, and one or more of the group of all forms of 5-hydroxytryptophan and L-tryptophan, all from either natural or synthetic sources ,(2004)
Elizabeth Mazzio, Comprehensive nutraceutical agent for treatment/ prevention of Parkinson's disease ,(2006)
Joerg G. D. Birkmayer, NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome ,(1996)
Johannes Huber, Concentration-enhancing drink ,(2011)
Joerg G. D. Birkmayer, Method for treating symptoms of Alzheimer's with NADH and NADPH ,(1993)
Kyl L. Smith, Nutritional supplements for healthy memory and mental function ,(2008)
Peter-Andreas Loschmann, Helmut Wachtel, Reinhard Horowski, Walter Birkmayer, Walther Birkmayer, Jorg Birkmayer, Agent for treatment of parkinson's disease ,(1989)
Gerardo Castillo, Alan D. Snow, Paula Y. Choi, Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses ,(2000)
Yo Sasaki, Jeffrey Milbrandt, Toshiyuki Araki, Methods and compositions for treating neuropathies ,(2005)
James David Adams, Suman Kumar Mukherjee, Lori Kathleen Klaidman, Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration ,(1996)